Back

9 Million Americans on Appetite-Suppressing Drugs Are Reshaping What Protein Looks Like on Amazon

Most Recent
Selling on Amazon
8.15.26
0
Min

The protein bar was built for this moment: concentrated, shelf-stable, portion-controlled. It's the one format losing ground. Amazon's data explains the paradox.

GLP-1 medications created the largest protein demand shock in a generation, and they did it by making people eat less.

Over 9 million Americans are now on Ozempic, Wegovy, Mounjaro, or a competitor. Clinical research shows that 25 to 40 percent of the weight lost on these drugs comes from lean mass rather than fat. A study presented at the Endocrine Society's annual meeting put the figure at roughly 40 percent for semaglutide users. The clinical response is now standard: 1.2 to 1.6 grams of protein per kilogram of body weight daily, roughly 90 to 120 grams for most adults, plus resistance training, to protect muscle during treatment.

At the same time, appetite falls by 30 to 50 percent.

That collision is the entire story. Millions of people were handed a protein target higher than they've ever hit, at the exact moment their capacity to eat collapsed. Every one of them became a shopper with an unusual and very specific set of constraints. SmartScout data shows Amazon's protein shelf reorganizing around those constraints in real time.

The Muscle Defense Signal Is The Clearest In The Dataset


The first thing a GLP-1 user hears is that they will lose muscle unless they intervene. The commerce response to that warning is already massive, and the biggest signal isn't protein.

Creatine generates $720.8M in annual revenue on Amazon, growing 90 percent year over year. The search term "creatine" draws 620,729 monthly searches and is up in every single tracking window SmartScout measures. Nothing else in this analysis grows in all four. Creatine is the most evidence-backed muscle preservation supplement available, and it's now standard in GLP-1 lean mass protocols.

Protein powder tracks alongside it at 603,335 monthly searches, up 59,279 year over year.

This is the purest GLP-1 signal on Amazon: not weight loss products, but muscle defense products.

Liquid Is Winning The Smaller Stomach


A 30 to 50 percent appetite reduction turns volume into the binding constraint. The question stops being "how many calories" and becomes "how much protein fits before I physically cannot continue."

Liquid wins that math, and the data is unambiguous.

Format Monthly Revenue Annual Revenue YoY Growth
Protein Drinks $50.2M $633M +42%
Protein Bars $30.0M $578M* Standing still

*Parent Nutrition Bars category; Protein Bars subcategory is flat within it. Source: SmartScout

The search data tells the same story, only sharper:

Search Term 12-Month Change Direction
Protein shake +56,747 📈 Up across all windows
Protein drinks +115,940 📈 Up 78% YoY
Protein bar -2,579 📉 Down
Protein chips -9,584 📉 Down, accelerating


Same nutrient. Same consumer. Opposite direction. Liquid gained roughly 57,000 searches over twelve months. Solid lost 2,600.

Ready-to-drink protein is the format that answers the volume constraint. Thirty grams, no chewing, no satiety penalty, tolerable when nauseated. Core Power and Premier Protein now split 55 percent of that category, and each spends around 15 percent of its ad dollars defending the position. That's why "protein drinks" costs $9.72 per click while cottage cheese costs $0.70.

The Protein Bar's Real Problem Isn't The Format. It's The Ingredients.


This is the constraint the industry has not priced in, and it's where the protein bar breaks.

GLP-1 drugs work partly by slowing gastric emptying. The documented consequences are nausea, constipation, bloating, and reflux. Everything downstream slows with it.

Sugar alcohols are the standard tool for making a high-protein bar taste sweet without sugar. They're also a well-documented cause of bloating, gas, and GI distress in people with normal digestion. For someone whose stomach is already emptying at half speed, they're not a minor tradeoff. They're a trigger.

The brand leaderboard reflects exactly that:

Brand Monthly Revenue Share Change (Month) Revenue Change (Month)
Quest $5.43M (18.1% share) -0.3% -$844K
BAREBELLS $3.03M (10.1% share) +1.6% +129K
Pure Protein $2.40M (8% share) -0.8% -$595K
Built Bar $1.59M (5.3% share) -1.4% -$577K
TRUBAR $1.20M (4% share) +0.2% -102K
MET-Rx $822K (2.7% share) +0.2% -29K
Power Crunch $817K (2.7% share) -0.4% -$258K

Source: SmartScout, U.S. Amazon marketplace, August 2026

Of the top 12 protein bar brands by revenue, 10 lost revenue month over month.

And the one brand taking meaningful share is doing something that should not work on paper.

The Brand Winning The Protein Bar Shelf Has 40% Less Protein


TRUBAR is gaining share with 12 grams of protein per bar against Quest's roughly 20. Forty percent less of the nutrient the entire category competes on.

What TRUBAR's product titles instead repeatedly lead with is "No Sugar Alcohols," alongside 12 grams of fiber. Its top listings rate ranges from 4.3 to 4.8, compared with a category average of 4.22.

A brand is taking share by offering less protein and better tolerability. That only makes sense if the marginal buyer's binding constraint is their gut, not their macros. That is a GLP-1 buyer.

Fiber tells a parallel story: "fiber supplement" draws 158,468 monthly searches and jumped 28,689 in the most recent month, consistent with a population managing constipation as a treatment side effect.

Real Food Is Beating Engineered Food, And The Ad Auctions Are Still Empty


When someone eats three times a day instead of six, each occasion carries more weight. In the search data, GLP-1 users are gravitating toward things that read as food rather than supplementation.

Category Monthly Revenue YoY Growth Monthly Searches Search Trend (Last Month) Advertisers CPC
Cottage Cheese $1.65M +291% 340,461 +102,756 9 $0.70
Greek Yogurt $4.89M +215% 298,774 +96,988 9 $1.32
Meat Snacks $20.6M +25% 15,841 11,249 $2.33
Protein Drinks $50.2M +42% 339,062 123,946 $9.72

Source: SmartScout


Those cottage cheese and Greek yogurt numbers deserve a second look. Each added roughly 100,000 searches in a single month. Each has just 9 advertisers. Each costs under $1.35 per click, while protein drinks cost $9.72. Cold chain logistics are harder, which is exactly why the auction is still empty.

Good Culture turned cottage cheese from a 1950s diet food into a protein brand and now holds 33.7 percent of the Amazon category with just seven products. Chomps overtook Jack Link's in jerky, $3.46M against $3.30M monthly, using 59 products against Jack Link's 215. Both are real food, clean label, and built for a shopper reading a macro target rather than browsing a snack aisle.

Inside The Bar Aisle, The Growth Is Everywhere Except The Protein Bar Shelf


Put those constraints together, and the protein bar should be the defining product of the GLP-1 era. Concentrated protein, shelf-stable, no preparation, portion controlled. Instead, the growth inside Amazon's bar aisle is routing around the main shelf entirely.

Subcategory Monthly Revenue YoY Growth Brands
Nutrition Bars (unclassified) $1.20M +143% 40
Endurance & Energy Bars $2.74M +49% 68
Food Bars $3.03M +20% 85
Protein Bars $30.0M Flat 364

Source: SmartScout


Protein Bars is the largest subcategory by a wide margin, the most crowded (364 brands, 2,882 products, averaging 612 sellers per listing), and the only one not moving. The sparse formats are compounding at double and triple-digit rates. The dominant one is standing still.

The GLP-1 demand wave did not skip the bar aisle. It routed around the main shelf.

The Brand That Understood: Protein Donuts Outselling Protein Bars


Legendary Foods is the largest share gainer in Food Bars, adding 6.3 points of share and roughly $194,000 in monthly revenue in a single month. It does not sell bars. It sells high-protein cinnamon pastries at $186,000 per month, chocolate pastries at $154,000, strawberry pastries at $130,000, cinnamon rolls at $100,000, and protein donuts that rank number one in Amazon's Donuts subcategory outright.

Its ratings sit between 3.9 and 4.2, below the category average. It's not winning on execution. It's winning because to someone eating three small meals a day with reduced appetite and shifting taste preferences, a protein donut is food and a protein bar is a supplement. Same macros, entirely different proposition.

The Tell: Nobody Is Searching For The Drug


The Amazon search term "glp 1" draws 27,725 monthly searches and is down roughly 4,900 year over year.

That may be the most useful number in this entire analysis. The GLP-1 commerce wave is not visible in GLP-1 searches. Shoppers aren't typing the medication into Amazon. They're typing creatine, protein shake, cottage cheese, and Greek yogurt. The brands capturing them are the ones that solved for the physiology without ever naming the cause.

What Smartscout's Data Adds Up To


The signals across the dataset point in one direction:

  • Build for the constraint, not the macro. The GLP-1 shopper isn't short on convenience. They're short on appetite, volume, and gut tolerance. Every category winning right now solves one of those three. Every category losing is optimized for grams per dollar.
  • Tolerability is wide-open positioning. TRUBAR is gaining share with 40 percent less protein and a "no sugar alcohols" claim. No major incumbent is competing on gastrointestinal comfort for a population of millions who now need it most.
  • Format is beating formulation. Legendary Foods grew by putting protein into pastries and donuts. Inside the bar family, the fastest growing subcategories are the ones not called protein bars.
  • The cheap traffic is refrigerated. Cottage cheese and Greek yogurt each draw roughly 300,000 monthly searches with under 10 advertisers and CPCs below $1.35. Protein drinks cost $9.72. Cold chain is harder. That's why the opportunity is still sitting there.
  • Never name the drug. Searches for "glp 1" on Amazon are falling. The brands winning are answering the symptom.

Protein has never sold better on Amazon. The protein bar missed the wave, because it was engineered for an appetite that 9 million of its best prospective customers no longer have.

Data: SmartScout, U.S. Amazon marketplace, trailing 12 months through August 2026. Clinical context: Endocrine Society, published GLP-1 body composition and side effect research.

Start Using SmartScout with Risk-Free Pricing

try it today
7-day money back guarantee, cancel at any time